查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1503433

到 2030 年数位治疗 (DTx) 市场预测：按产品、收益形式、销售管道、应用和地区进行的全球分析

Digital Therapeutics Market Forecasts to 2030 - Global Analysis By Offering, Revenue Modal, Sales Channel, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC预测，2024年全球数位治疗（DTx）市场规模将达到109.9亿美元，并在预测期内以30.0%的复合年增长率成长，到2030年将达到530.2亿美元。

数位疗法 (DTx) 是基于软体的干预措施，旨在预防、管理和治疗医疗状况。与传统药物不同，DTx 透过行动应用、穿戴式装置和虚拟实境等数位平台提供治疗性介入。这些介入措施通常利用认知行为疗法、正念技术和个人化演算法等元素来解决各种健康问题，例如精神健康障碍、慢性疾病和药物滥用。 DTx 提供了一种可扩展、可存取且经济高效的解决方案，使个人能够在传统医疗保健环境之外控制自己的健康。

根据国际糖尿病联盟（IDF）糖尿病图谱发布的2022年报告估计，2022年新增1型糖尿病病例中62.0%为20岁或以上。

医疗费用上涨

不断上涨的医疗保健成本是推动数位治疗（DTx）市场成长的主要因素。随着传统医疗保健成本持续上升，对经济高效、易于使用的解决方案的需求日益增长。 DTx 提供了一种很有前景的选择，它利用技术为各种疾病状态提供基于证据的干预措施，而成本仅为传统治疗的一小部分。由于具有透过远端监控、个人化介入和改善患者治疗结果来减少医疗保健支出的潜力，DTx 越来越被认为是控制医疗保健成本上升的关键因素。

资料隐私和安全问题

数位治疗 (DTx) 市场中的资料隐私和安全问题围绕着保护敏感患者资讯和确保治疗资料的完整性。个人健康资料的收集和分析会增加违规风险，并可能导致潜在的剥削和身分盗窃。此外，保持机密性对于在患者和 DTx 提供者之间建立信任关係至关重要。需要强大的安全措施来防止未授权存取、伪造和洩露健康资料，并且必须遵守美国HIPAA（健康保险互通性和课责法案）和欧盟的 GDPR（通用资料保护条例）。

与穿戴式装置和感测器集成

与穿戴式装置和感测器的整合透过增强即时监控和个人化治疗交付为数位治疗 (DTx) 市场带来了重大机会。透过与智慧型手錶和健身追踪器等穿戴式装置连接，DTx平台可以收集连续的生物辨识资料，从而实现更准确的健康状况和治疗调整。这种整合有利于远端患者监控，并允许医疗保健提供者主动干预并根据患者的个人需求量身定制干预措施。穿戴式装置整合透过提供无缝的使用者体验和即时回馈来促进患者的参与和依从性。

医疗保健差异和获取机会

数位疗法 (DTx) 的出现有望透过提供便利、可及和个人化的治疗来彻底改变医疗保健服务。然而，对健康差异和准入的担忧笼罩着这个快速成长的市场。 DTx 有潜力覆盖广泛的人群，包括服务不足的社区，但由于技术素养、智慧型手机和网路连线的使用以及社会经济地位等因素，可能存在差异。

COVID-19 的影响：

随着人们寻求远距医疗解决方案，COVID-19 大流行显着加速了数位疗法 (DTx) 的采用。在封锁和社交距离措施的影响下，对包括数位治疗在内的虚拟医疗服务的需求激增。此次疫情凸显了对可近且便利的医疗保健选择的需求，导致 DTX 市场的投资和创新增加。整合数位疗法的远端医疗平台迅速普及，为糖尿病、精神疾病和高血压等慢性病提供个人化治疗方案。

软体/平台产业预计将在预测期内成为最大的产业

由于几个关键因素，数位治疗 (DTx) 市场的软体/平台部分正在经历强劲成长。数位健康解决方案和穿戴式装置的日益普及增加了对促进 DTx 介入的软体平台的需求。此外，人工智慧和机器学习演算法等技术的进步使得更复杂和个人化的数位治疗解决方案的开发成为可能。此外，对预防性医疗保健的重视和慢性病盛行率的上升正在推动对数位疗法的需求。

治疗/护理相关应用预计在预测期内将经历最高的复合年增长率

由于糖尿病、高血压、肥胖等慢性病的盛行率不断上升，数位治疗（DTx）市场中与治疗/护理相关的应用领域不断增长，增加了对该领域提供的远端监控和管理解决方案的需求我们正在经历显着的成长。科技的进步，特别是穿戴式装置和行动医疗应用程式的进步，使得追踪患者病情进展和提供个人化介入变得更加容易。此外，远端医疗和虚拟护理模式的日益普及进一步支持了治疗和护理相关 DTx 应用的扩展。

比最大的地区

北美雷射加工市场的成长得益于几个关键因素。科技的进步促进了更有效率、更精确的雷射加工系统的发展，这些系统越来越多地被汽车、电子和医疗保健等多种行业采用。该地区（尤其是美国）强劲的製造业正在推动切割、焊接和打标等应用中对雷射加工解决方案的需求。此外，业界对自动化和生产力提高的日益重视进一步推动了雷射加工技术的采用。此外，增加旨在增强雷射加工能力的研发活动的投资也有助于该地区的市场成长。

复合年增长率最高的地区：

由于多种因素，亚太地区的雷射加工市场正在经历显着成长。特别是中国、日本、韩国等国家的製造业正快速成长，汽车、电子、医疗保健等各行业对雷射加工技术的需求不断增加。此外，雷射技术的进步，包括精度和效率的提高，正在推动采用率。主要市场参与企业增加研发投资以及政府促进创新的措施进一步支持市场扩张。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球数位治疗 (DTx) 市场：依产品分类

  • 程式
  • 软体/平台
  • 虚拟实境/游戏

第六章全球数位治疗 (DTx) 市场：按收益类型

  • 基于结果/价值
  • 订阅
  • 一次性购买/许可

第七章全球数位治疗（DTx）市场：依销售管道

  • B2C
    • 病人
    • 看护者
  • B2B
    • 付款人
    • 雇主
    • 製药公司
    • 提供者

第八章全球数位治疗 (DTx) 市场：依应用分类

  • 预防性使用
    • 糖尿病前期
    • 肥胖
    • 营养
    • 生活方式管理
    • 其他预防性应用
  • 治疗/护理相关应用
    • 糖尿病
    • 中枢神经系统疾病
    • 精神障碍
    • 慢性呼吸道疾病
    • 肌肉骨骼疾病
    • 心血管疾病
    • 禁止抽烟
    • 用药依从性
    • 胃肠道疾病
    • 管理药物使用和成瘾
    • 復健和患者照护
    • 失眠
    • 高血压
    • 其他治疗/护理相关用途

第九章全球数位治疗（DTx）市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Akili Interactive Labs
  • Biofourmis, Inc.
  • Brain+A/S
  • CureApp, Inc.
  • DarioHealth
  • Fitbit Health Solutions
  • Gaia AG
  • Lark Health
  • LifeScan, Inc.
  • Omada Health Inc
  • Otsuka Holdings Co., Ltd.
  • Pear Therapeutics Inc
  • ResMed
  • Teladoc Health
  • Virta Health Corp
  • WellDoc, Inc.
Product Code: SMRC26603

According to Stratistics MRC, the Global Digital Therapeutics (DTx) Market is accounted for $10.99 billion in 2024 and is expected to reach $53.02 billion by 2030 growing at a CAGR of 30.0% during the forecast period. Digital therapeutics (DTx) are software-based interventions designed to prevent, manage, or treat medical conditions. Unlike traditional pharmaceuticals, DTx delivers therapeutic interventions through digital platforms such as mobile apps, wearables, or virtual reality. These interventions often leverage elements of cognitive behavioral therapy, mindfulness techniques, or personalized algorithms to address various health issues, including mental health disorders, chronic diseases, and substance abuse. DTx offers scalable, accessible, and cost-effective solutions, empowering individuals to take control of their health outside of traditional healthcare settings.

According to the 2022 report estimates published by the International Diabetes Federation (IDF) Diabetes Atlas, 62.0% of all new Type 1 Diabetes cases in 2022 were in people aged 20 years or older.

Market Dynamics:

Driver:

Rising healthcare costs

Rising healthcare costs serve as a major driver propelling the growth of the digital therapeutics (DTx) market. As traditional healthcare expenses continue to surge, there's a growing need for cost-effective and accessible solutions. DTx offers a promising alternative, leveraging technology to deliver evidence-based interventions for various medical conditions at a fraction of the cost of conventional treatments. With the potential to reduce healthcare expenditures through remote monitoring, personalized interventions, and improved patient outcomes, DTx are increasingly recognized as a vital component in the quest to curb escalating healthcare costs.

Restraint:

Data privacy and security concerns

Data privacy and security concerns in the digital therapeutics (DTx) market revolve around safeguarding sensitive patient information and ensuring the integrity of treatment data. With the collection and analysis of personal health data, there's a heightened risk of breaches, leading to potential exploitation or identity theft. Moreover, maintaining confidentiality is crucial to building trust between patients and DTx providers. Security measures must be robust to prevent unauthorized access, tampering, or leaks of health data, ensuring compliance with regulations like HIPAA (Health Insurance Portability and Accountability Act) in the U.S. and GDPR (General Data Protection Regulation) in the European Union.

Opportunity:

Integration with wearable devices and sensors

Integration with wearable devices and sensors presents a significant opportunity in the digital therapeutics (DTx) market by enhancing real-time monitoring and personalized treatment delivery. By connecting with wearables like smartwatches and fitness trackers, DTx platforms can gather continuous biometric data, enabling more accurate health insights and treatment adjustments. This integration facilitates remote patient monitoring, allowing healthcare providers to intervene proactively and tailor interventions to individual patients needs. Wearable integration promotes patient engagement and adherence by offering a seamless user experience and real-time feedback.

Threat:

Health inequities and access

The emergence of digital therapeutics (DTx) holds promise for revolutionizing healthcare delivery by offering convenient, accessible, and personalized treatments. However, there's a looming concern regarding health inequities and access within this burgeoning market. While DTx has the potential to reach a wide audience, including underserved communities, disparities may arise due to factors like technological literacy, access to smartphones or internet connectivity, and socioeconomic status.

Covid-19 Impact:

The COVID-19 pandemic has significantly accelerated the adoption of digital therapeutics (DTx) as people seek remote healthcare solutions. With lockdowns and social distancing measures in place, there was a surge in demand for virtual healthcare services, including digital therapeutics. The pandemic highlighted the need for accessible and convenient healthcare options, leading to increased investment and innovation in the DTX market. Telemedicine platforms integrating digital therapeutics saw a rapid uptake, offering personalized treatment plans for chronic conditions like diabetes, mental health disorders, and hypertension.

The software/platforms segment is expected to be the largest during the forecast period

The software/platforms segment in the digital therapeutics (DTx) market has experienced robust growth due to several key factors. The increasing adoption of digital health solutions and wearable devices has propelled demand for software platforms that facilitate the delivery of DTx interventions. Additionally, advancements in technology, such as artificial intelligence and machine learning algorithms, have enabled the development of more sophisticated and personalized digital therapeutic solutions. Furthermore, the emphasis on preventive healthcare and the rising prevalence of chronic diseases have fueled the demand for digital therapeutics.

The treatment/care-related applications segment is expected to have the highest CAGR during the forecast period

The Treatment/Care-related Applications segment in the Digital Therapeutics (DTx) market has witnessed substantial growth due to the increasing prevalence of chronic diseases like diabetes, hypertension, and obesity has amplified the demand for remote monitoring and management solutions, which this segment provides. Advancements in technology, particularly in wearables and mobile health apps, have made it easier to track patient progress and deliver personalized interventions. Additionally, the rising adoption of telemedicine and virtual care models has further propelled the expansion of treatment- and care-related DTx applications.

Region with largest share:

The growth of the laser processing market in North America can be attributed to several key factors. Technological advancements have led to the development of more efficient and precise laser processing systems, increasing their adoption across various industries, including automotive, electronics, and healthcare. The region's robust manufacturing sector, particularly in the United States, has fueled demand for laser processing solutions for applications such as cutting, welding, and marking. Additionally, the rising emphasis on automation and productivity enhancement in industries has further propelled the uptake of laser processing technologies. Moreover, increasing investments in research and development activities aimed at enhancing laser processing capabilities have also contributed to market growth in the region.

Region with highest CAGR:

The Asia-Pacific region's laser processing market has witnessed substantial growth due to several factors. The region's burgeoning manufacturing sector, particularly in countries like China, Japan, and South Korea, has driven the demand for laser processing technologies across various industries such as automotive, electronics, and healthcare. Additionally, advancements in laser technology, including improved precision and efficiency, have fuelled adoption rates. Increasing investments in research and development by key market players and government initiatives promoting technological innovation have further propelled market expansion.

Key players in the market

Some of the key players in Digital Therapeutics (DTx) market include Akili Interactive Labs, Biofourmis, Inc., Brain+ A/S, CureApp, Inc., DarioHealth, Fitbit Health Solutions, Gaia AG, Lark Health, LifeScan, Inc., Omada Health Inc, Otsuka Holdings Co., Ltd., Pear Therapeutics Inc, ResMed, Teladoc Health, Virta Health Corp and WellDoc, Inc.

Key Developments:

In June 2024, Google recently introduced Fitbit Ace LTE - "a new, first-of-its-kind connected smartwatch for kids ages 7+. Ace LTE transforms exercise into play, while also giving families peace of mind with reliable calling, messaging and location sharing with parents." The company's VP of Product, Anil Sabharwal, said in a blog post.

In March 2024, Digital health company Welldoc has secured CE mark certification for its BlueStar mobile app, unlocking the advancement of its solutions in Europe. The app has been certified as a Class IIa medical device under the EU Medical Device Regulation.

Offerings Covered:

  • Programs
  • Software/Platforms
  • Virtual Reality/Games

Revenue Modals Covered:

  • Outcome/Value based
  • Subscription
  • One time Purchase/Licensing

Sales Channels Covered:

  • Business to Customer
  • Business to Business

Applications Covered:

  • Preventive Applications
  • Treatment/Care-related Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Digital Therapeutics (DTx) Market, By Offering

  • 5.1 Introduction
  • 5.2 Programs
  • 5.3 Software/Platforms
  • 5.4 Virtual Reality/Games

6 Global Digital Therapeutics (DTx) Market, By Revenue Modal

  • 6.1 Introduction
  • 6.2 Outcome/Value based
  • 6.3 Subscription
  • 6.4 One time Purchase/Licensing

7 Global Digital Therapeutics (DTx) Market, By Sales Channel

  • 7.1 Introduction
  • 7.2 Business to Customer
    • 7.2.1 Patients
    • 7.2.2 Caregivers
  • 7.3 Business to Business
    • 7.3.1 Payers
    • 7.3.2 Employers
    • 7.3.3 Pharmaceutical Companies
    • 7.3.4 Providers

8 Global Digital Therapeutics (DTx) Market, By Application

  • 8.1 Introduction
  • 8.2 Preventive Applications
    • 8.2.1 Prediabetes
    • 8.2.2 Obesity
    • 8.2.3 Nutrition
    • 8.2.4 Lifestyle Management
    • 8.2.5 Other Preventive Applications
  • 8.3 Treatment/Care-related Applications
    • 8.3.1 Diabetes
    • 8.3.2 Central nervous system Disorders
    • 8.3.3 Mental Health Disorder
    • 8.3.4 Chronic Respiratory Disorders
    • 8.3.5 Musculoskeletal Disorders
    • 8.3.6 Cardiovascular Diseases
    • 8.3.7 Smoking Cessation
    • 8.3.8 Medication Adherence
    • 8.3.9 Gastrointestinal Disorders
    • 8.3.10 Substance Use & Addiction Management
    • 8.3.11 Rehabilitation & Patient Care
    • 8.3.12 Insomnia
    • 8.3.13 Hypertension
    • 8.3.14 Other Treatment/Care-related Applications

9 Global Digital Therapeutics (DTx) Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Akili Interactive Labs
  • 11.2 Biofourmis, Inc.
  • 11.3 Brain+ A/S
  • 11.4 CureApp, Inc.
  • 11.5 DarioHealth
  • 11.6 Fitbit Health Solutions
  • 11.7 Gaia AG
  • 11.8 Lark Health
  • 11.9 LifeScan, Inc.
  • 11.10 Omada Health Inc
  • 11.11 Otsuka Holdings Co., Ltd.
  • 11.12 Pear Therapeutics Inc
  • 11.13 ResMed
  • 11.14 Teladoc Health
  • 11.15 Virta Health Corp
  • 11.16 WellDoc, Inc.

List of Tables

  • Table 1 Global Digital Therapeutics (DTx) Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Digital Therapeutics (DTx) Market Outlook, By Offering (2022-2030) ($MN)
  • Table 3 Global Digital Therapeutics (DTx) Market Outlook, By Programs (2022-2030) ($MN)
  • Table 4 Global Digital Therapeutics (DTx) Market Outlook, By Software/Platforms (2022-2030) ($MN)
  • Table 5 Global Digital Therapeutics (DTx) Market Outlook, By Virtual Reality/Games (2022-2030) ($MN)
  • Table 6 Global Digital Therapeutics (DTx) Market Outlook, By Revenue Modal (2022-2030) ($MN)
  • Table 7 Global Digital Therapeutics (DTx) Market Outlook, By Outcome/Value based (2022-2030) ($MN)
  • Table 8 Global Digital Therapeutics (DTx) Market Outlook, By Subscription (2022-2030) ($MN)
  • Table 9 Global Digital Therapeutics (DTx) Market Outlook, By One time Purchase/Licensing (2022-2030) ($MN)
  • Table 10 Global Digital Therapeutics (DTx) Market Outlook, By Sales Channel (2022-2030) ($MN)
  • Table 11 Global Digital Therapeutics (DTx) Market Outlook, By Business to Customer (2022-2030) ($MN)
  • Table 12 Global Digital Therapeutics (DTx) Market Outlook, By Patients (2022-2030) ($MN)
  • Table 13 Global Digital Therapeutics (DTx) Market Outlook, By Caregivers (2022-2030) ($MN)
  • Table 14 Global Digital Therapeutics (DTx) Market Outlook, By Business to Business (2022-2030) ($MN)
  • Table 15 Global Digital Therapeutics (DTx) Market Outlook, By Payers (2022-2030) ($MN)
  • Table 16 Global Digital Therapeutics (DTx) Market Outlook, By Employers (2022-2030) ($MN)
  • Table 17 Global Digital Therapeutics (DTx) Market Outlook, By Pharmaceutical Companies (2022-2030) ($MN)
  • Table 18 Global Digital Therapeutics (DTx) Market Outlook, By Providers (2022-2030) ($MN)
  • Table 19 Global Digital Therapeutics (DTx) Market Outlook, By Application (2022-2030) ($MN)
  • Table 20 Global Digital Therapeutics (DTx) Market Outlook, By Preventive Applications (2022-2030) ($MN)
  • Table 21 Global Digital Therapeutics (DTx) Market Outlook, By Prediabetes (2022-2030) ($MN)
  • Table 22 Global Digital Therapeutics (DTx) Market Outlook, By Obesity (2022-2030) ($MN)
  • Table 23 Global Digital Therapeutics (DTx) Market Outlook, By Nutrition (2022-2030) ($MN)
  • Table 24 Global Digital Therapeutics (DTx) Market Outlook, By Lifestyle Management (2022-2030) ($MN)
  • Table 25 Global Digital Therapeutics (DTx) Market Outlook, By Other Preventive Applications (2022-2030) ($MN)
  • Table 26 Global Digital Therapeutics (DTx) Market Outlook, By Treatment/Care-related Applications (2022-2030) ($MN)
  • Table 27 Global Digital Therapeutics (DTx) Market Outlook, By Diabetes (2022-2030) ($MN)
  • Table 28 Global Digital Therapeutics (DTx) Market Outlook, By Central nervous system Disorders (2022-2030) ($MN)
  • Table 29 Global Digital Therapeutics (DTx) Market Outlook, By Mental Health Disorder (2022-2030) ($MN)
  • Table 30 Global Digital Therapeutics (DTx) Market Outlook, By Chronic Respiratory Disorders (2022-2030) ($MN)
  • Table 31 Global Digital Therapeutics (DTx) Market Outlook, By Musculoskeletal Disorders (2022-2030) ($MN)
  • Table 32 Global Digital Therapeutics (DTx) Market Outlook, By Cardiovascular Diseases (2022-2030) ($MN)
  • Table 33 Global Digital Therapeutics (DTx) Market Outlook, By Smoking Cessation (2022-2030) ($MN)
  • Table 34 Global Digital Therapeutics (DTx) Market Outlook, By Medication Adherence (2022-2030) ($MN)
  • Table 35 Global Digital Therapeutics (DTx) Market Outlook, By Gastrointestinal Disorders (2022-2030) ($MN)
  • Table 36 Global Digital Therapeutics (DTx) Market Outlook, By Substance Use & Addiction Management (2022-2030) ($MN)
  • Table 37 Global Digital Therapeutics (DTx) Market Outlook, By Rehabilitation & Patient Care (2022-2030) ($MN)
  • Table 38 Global Digital Therapeutics (DTx) Market Outlook, By Insomnia (2022-2030) ($MN)
  • Table 39 Global Digital Therapeutics (DTx) Market Outlook, By Hypertension (2022-2030) ($MN)
  • Table 40 Global Digital Therapeutics (DTx) Market Outlook, By Other Treatment/Care-related Applications (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.